Literature DB >> 22796586

Mycobacterium indicus pranii mediates macrophage activation through TLR2 and NOD2 in a MyD88 dependent manner.

Rajeev Kumar Pandey1, Ajit Sodhi, Subhra K Biswas, Yogesh Dahiya, Manprit K Dhillon.   

Abstract

Mycobacterium indicus pranii (MIP) is a non-pathogenic strain of mycobacterium and has been used as a vaccine against tuberculosis and leprosy. Here, we investigated the role of different pattern recognition receptors in the recognition of heat-killed MIP by macrophages. Treatment of macrophages with MIP caused upregulation of pro-inflammatory cytokines (like TNFα and IL-1β) which was mediated through both TLR2 and NOD2, as revealed by our knockdown and/or knockout studies. Mechanistically, MIP-induced macrophage activation was shown to result in NF-κB activation and drastically abrogated by MyD88 deficiency, suggesting its regulation via an MyD88-dependent, NF-κB pathway. Interestingly, the IFN-inducible cytokine, CXCL10, which is known target of the TRIF-dependent TLR pathway was found to be upregulated in response to MIP but, in an MyD88-dependent manner. Collectively, these results demonstrate macrophages to recognize and respond to MIP through a TLR2, NOD2 and an MyD88-dependent pathway. However, further studies should clarify whether additional TLR-dependent or -independent pathways also exist in regulating the full spectrum of MIP action on macrophage activation.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796586     DOI: 10.1016/j.vaccine.2012.07.002

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  MyD88 in Mycobacterium tuberculosis infection.

Authors:  Jorge L Cervantes
Journal:  Med Microbiol Immunol       Date:  2017-02-20       Impact factor: 3.402

2.  Combination of Mycobacterium indicus pranii and Heat-Induced Promastigotes Cures Drug-Resistant Leishmania Infection: Critical Role of Interleukin-6-Producing Classical Dendritic Cells.

Authors:  Somaditya Dey; Debarati Mukherjee; Sirin Salma Sultana; Suvadip Mallick; Aritri Dutta; Joydip Ghosh; Aabid Hussain; Biswajyoti Sarkar; Supratim Mandal; Pradyumna Patra; Bhaskar Saha; Chiranjib Pal
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

3.  Targeting Toll-Like Receptors for Cancer Therapy.

Authors:  Marc J Braunstein; John Kucharczyk; Sylvia Adams
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

4.  Nucleotide-Binding Oligomerization Domain 2 Contributes to Limiting Growth of Mycobacterium abscessus in the Lung of Mice by Regulating Cytokines and Nitric Oxide Production.

Authors:  Jun-Young Lee; Moo-Seung Lee; Dong-Jae Kim; Soo-Jin Yang; Sang-Jin Lee; Eui-Jeong Noh; Sung Jae Shin; Jong-Hwan Park
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

5.  A randomised trial of Mycobacterium w in critically ill patients with COVID-19: ARMY-1.

Authors:  Inderpaul Singh Sehgal; Randeep Guleria; Sarman Singh; Mohammad Sabah Siddiqui; Ritesh Agarwal
Journal:  ERJ Open Res       Date:  2021-04-12

6.  Cytokine Storm and Immunomodulation in COVID-19.

Authors:  Pradeep Rangappa
Journal:  Indian J Crit Care Med       Date:  2021-11

7.  Leishmania donovani-Induced Increase in Macrophage Bcl-2 Favors Parasite Survival.

Authors:  Rajeev Kumar Pandey; Sanjana Mehrotra; Smriti Sharma; Ramachandra Subbaraya Gudde; Shyam Sundar; Chandrima Shaha
Journal:  Front Immunol       Date:  2016-10-25       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.